Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H P Lohrmann

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Klinische Wochenschrift|July 15, 1978
Methacrylate-embedded bone marrow particle histologyH P Lohrmann, G Neu, W Schreml
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1982
Short-term and long-term effects of chemoimmunotherapy on granulopoiesis: adjuvant therapy of breast cancerH P Lohrmann, W Schreml, M Lang
Experimental Hematology|January 1, 1985
Stem cell defects after cytoreductive therapy in manW Schreml, H P Lohrmann, B Anger
British Journal of Haematology|March 1, 1976
Sodium pertechnetate as a red cell label: in vitro and in vivo studiesP Schmidt, H P Lohrmann, H Heimpel
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1978
[Reaction of the human granulopoiesis to large doses of cyclophosphamide]H P Lohrmann, W Schreml, H Heimpel
Scandinavian Journal of Haematology|February 1, 1982
Attempt at quantification of the cytotoxic drug-induced changes of the human bone marrow compartmentsW Schreml, P Kubitza, H P Lohrmann
Blut|February 1, 1978
Human placenta-conditioned medium for stimulation of human granulopoietic precursor cell (CFU-C) colony growth in vitroH P Lohrmann, W Hansi, H Heimpel
Journal of the National Cancer Institute|April 1, 1982
5-Fluorouracil, 1,3-bis(2-chloroethyl)-1-nitrosourea, and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea: effect on the human granulopoietic systemH P Lohrmann, K A Lepp, W Schreml
Nature|July 12, 1974
Stimulatory capacity of human T and B lymphocytes in the mixed leukocyte cultureH P Lohrmann, L Novikovs, R G Graw
Klinische Wochenschrift|July 1, 1975
[Supportive care in bone marrow failure. Technical, immunological and clinical advances]H P Lohrmann, S F Goldmann, W Adam
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Klinische Wochenschrift|July 15, 1978
Methacrylate-embedded bone marrow particle histologyH P Lohrmann, G Neu, W Schreml
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1982
Short-term and long-term effects of chemoimmunotherapy on granulopoiesis: adjuvant therapy of breast cancerH P Lohrmann, W Schreml, M Lang
Experimental Hematology|January 1, 1985
Stem cell defects after cytoreductive therapy in manW Schreml, H P Lohrmann, B Anger
British Journal of Haematology|March 1, 1976
Sodium pertechnetate as a red cell label: in vitro and in vivo studiesP Schmidt, H P Lohrmann, H Heimpel
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1978
[Reaction of the human granulopoiesis to large doses of cyclophosphamide]H P Lohrmann, W Schreml, H Heimpel
Scandinavian Journal of Haematology|February 1, 1982
Attempt at quantification of the cytotoxic drug-induced changes of the human bone marrow compartmentsW Schreml, P Kubitza, H P Lohrmann
Blut|February 1, 1978
Human placenta-conditioned medium for stimulation of human granulopoietic precursor cell (CFU-C) colony growth in vitroH P Lohrmann, W Hansi, H Heimpel
Journal of the National Cancer Institute|April 1, 1982
5-Fluorouracil, 1,3-bis(2-chloroethyl)-1-nitrosourea, and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea: effect on the human granulopoietic systemH P Lohrmann, K A Lepp, W Schreml
Nature|July 12, 1974
Stimulatory capacity of human T and B lymphocytes in the mixed leukocyte cultureH P Lohrmann, L Novikovs, R G Graw
Klinische Wochenschrift|July 1, 1975
[Supportive care in bone marrow failure. Technical, immunological and clinical advances]H P Lohrmann, S F Goldmann, W Adam
Pageof 6